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Abstract
Neurological diseases and trauma often cause demyelination, resulting in the disruption of axonal function
and integrity. Endogenous remyelination promotes recovery, but the process is not well understood because
no method exists to definitively distinguish regenerated from preexisting myelin. To date, remyelinated
segments have been defined as anything abnormally short and thin, without empirical data to corroborate
these morphological assumptions. To definitively identify regenerated myelin, we used a transgenic mouse
with an inducible membrane-bound reporter and targeted Cre recombinase expression to a subset of glial
progenitor cells after spinal cord injury, yielding remarkably clear visualization of spontaneously regenerated
myelin in vivo. Early after injury, the mean length of sheaths regenerated by Schwann cells and
oligodendrocytes (OLs) was significantly shorter than control, uninjured myelin, confirming past
assumptions. However, OL-regenerated sheaths elongated progressively over 6 mo to approach control values.
Moreover, OL-regenerated myelin thickness was not significantly different from control myelin at most time
points after injury. Thus, many newly formed OL sheaths were neither thinner nor shorter than control
myelin, vitiating accepted dogmas of what constitutes regenerated myelin. We conclude that remyelination,
once thought to be static, is dynamic and elongates independently of axonal growth, in contrast to stretch-
based mechanisms proposed in development. Further, without clear identification, past assessments have
underestimated the extent and quality of regenerated myelin.
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Neurological diseases and trauma often cause demyelination, re-
sulting in the disruption of axonal function and integrity. Endoge-
nous remyelination promotes recovery, but the process is not well
understood because no method exists to deﬁnitively distinguish
regenerated from preexisting myelin. To date, remyelinated seg-
ments have been deﬁned as anything abnormally short and thin,
without empirical data to corroborate these morphological assump-
tions. To deﬁnitively identify regenerated myelin, we used a trans-
genic mouse with an inducible membrane-bound reporter and
targeted Cre recombinase expression to a subset of glial progenitor
cells after spinal cord injury, yielding remarkably clear visualizationof
spontaneously regenerated myelin in vivo. Early after injury, the
mean length of sheaths regenerated by Schwann cells and oligoden-
drocytes (OLs) was signiﬁcantly shorter than control, uninjured
myelin, conﬁrming past assumptions. However, OL-regenerated
sheaths elongated progressively over 6 mo to approach control
values. Moreover, OL-regenerated myelin thickness was not signif-
icantly different from control myelin at most time points after injury.
Thus, many newly formed OL sheaths were neither thinner nor
shorter than control myelin, vitiating accepted dogmas of what
constitutes regenerated myelin. We conclude that remyelination,
once thought to be static, is dynamic and elongates independently of
axonal growth, in contrast to stretch-based mechanisms proposed in
development. Further, without clear identiﬁcation, past assessments
have underestimated the extent and quality of regenerated myelin.
regeneration | plasticity | internode
Nervous system disorders including traumatic injury, stroke,and neurodegenerative diseases such as multiple sclerosis
induce loss of myelin and myelinating cells, interrupting signal
conduction and depriving axons of trophic support essential for
survival (1–4). Postmitotic oligodendrocytes (OLs) do not readily
participate in remyelination (5, 6). Instead, glial progenitors, dis-
tinguished by expression of the α-receptor for PDGF and the
chondroitin sulfate proteoglycan neural/glial antigen 2 (NG2)
proliferate following demyelination and differentiate into remye-
linating cells within a few weeks (7–10). Regeneration of myelin
membranes restores saltatory conduction and supports axonal
integrity, leading to partial recovery of function (3, 4, 11, 12).
However, remyelination can fail during disease progression, and
limited or abnormal myelin regeneration is thought to underlie
chronic conduction deﬁcits following trauma (11, 13, 14). En-
hancing or substituting endogenous remyelination via pharmaco-
logical intervention or stem/progenitor cell transplantation has
been a major, but unrealized, focus of clinical therapy develop-
ment for decades (15–17).
There is much we do not understand about spontaneous remye-
lination, including the rate of OL regeneration, whether remyeli-
nating cells select speciﬁc phenotypes or morphotypes of axons to
ensheathe, and whether the initial number, thickness, or length of
myelin internodes are dynamic. This is partly because no methods
exist to deﬁnitively discriminate spontaneously regenerating myelin
membranes from spared or degenerating sheaths. There are also no
known molecular markers for regenerating myelin. Much of our
understanding of myelin replacement is instead derived from in-
terpretation of small-ﬁeld EM or quantiﬁcation of indirect histo-
logical markers (14, 18–21). Groundbreaking EM studies in the
1960s and 1970s conﬁrmed the phenomenon of central remyelina-
tion, revealing thin, loosely wrapped sheaths that resembled im-
mature myelin (18) as well as abnormally short myelin internodes
(20) a few weeks after demyelination. Since that time, abnormally
thin or short sheaths have been presumed to represent regenerated
myelin. Investigators still commonly use these morphological char-
acteristics alone to identify and study remyelination (11, 19, 20, 22).
This approach has likely limited understanding of the endoge-
nous regeneration process. Measuring sheath length or thickness
does not empirically determine whether a myelin sheath is new,
degenerating, or preserved. Inappropriately thin and shortened
myelin segments also result from partial demyelination of de-
velopmentally generated sheaths (23–25). Furthermore, it has
long been suspected that internodes with normal proportions
could be formed by remyelinating cells (19). If regenerated sheaths
were able to thicken or elongate over time, for example, they
would be morphologically indistinguishable from normal myelin.
In short, we cannot be sure that all abnormally thin or short myelin
is regenerated, nor that all sheaths with normal dimensions are
a product of development rather than regeneration.Myelin sheath
dimensions affect signal conduction speed considerably, and
sluggish conduction following insult has been attributed in part to
irregular remyelination (11, 12, 26–29). A better comprehension
of these fundamentals is essential in guiding a new understanding
of spontaneous myelin regeneration and therapeutic approaches
to demyelinating disorders.
To follow the evolution and maturation of regenerating myelin
membranes, we used a model of spinal cord contusion injury
known to cause signiﬁcant partial demyelination of spared axons
followed by spontaneous remyelination (28). We targeted re-
porter expression to the membranes of proliferating NG2+ glial
progenitors via postinjury retrovirus injections in a mouse strain
that ubiquitously expresses membrane-bound GFP following Cre
recombination (30). Our ﬁndings revealed dynamic remodeling
of myelin internodes over time and challenge several morpho-
logical dogmas in regard to how regenerated myelin forms.
Results
Cre-Mediated Recombination Is Evident in Premyelinating Glial
Progenitors Acutely After Injury. To generate a reporter system for
remyelination, three essential elements were combined (Fig. S1).
(i) Remyelinating cells were speciﬁcally targeted by a combination
of the NG2 promoter (31) and a retrovirus that integrates DNA
into the host genome only during mitosis (32). We chose the NG2
promoter because it is expressed by resident glial progenitors that
can produce OLs and Schwann cells (SCs) after injury as well as by
inﬁltrating peripheral SCs that participate in central remyelination
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(10, 33–35). The promoter and its efﬁcient targeting of NG2+ glial
progenitors has been fully characterized previously (31). (ii) We
tracked the remyelination process over a long postinjury period by
using the Cre-loxp system to induce stable reporter gene expres-
sion. (iii) Clear visualization of myelin membranes was accom-
plished by using a membrane-targeted reporter, as most cytoplasm
is extruded from compact myelin (36). We used a mouse strain that
ubiquitously expresses membrane-targeted tandem dimer Tomato
(mT) but switches tomembrane-targetedGFP (mG) following Cre-
mediated recombination (30).We injected virus into spinal cords of
reporter mice 6 d after moderate thoracic contusion injury, when
many NG2+ progenitors that go on to remyelinate are thought to
proliferate (15, 34).
To ensure that virus targeted proliferating glial progenitor cells
rather than spared, postmitotic OLs, we examined spinal cord
sections of contused mice for mG expression 5 d post virus (DPV)
injection. At this time point, recombination in infected cells
should have induced a switch frommT to mG expression (30), but
myelin regeneration was unlikely to have begun (18). We there-
fore expected to ﬁnd mG+ cells, but not mG+ myelin sheaths.
Numerous perilesional mG+/mT− cells were observed at 5 DPV
(Fig. 1A). Some mG+ cells were highly NG2-immunopositive and
exhibited characteristic OL progenitor cell morphology (Fig. 1B).
As expected, no mG+ myelin was observed at 5 DPV. To further
establish that mG+ populations were not composed of postmitotic
cells and eliminate the possibility that preexisting myelin was la-
beled, animals received a single i.p. injection of the mitotic
marker BrdU concurrent with virus injection. We found at 5 DPV
that mG+ cells were BrdU+, indicating that they had undergone
division at the time of virus injections (Fig. 1C).
We examined tissue sections at 14 DPV to determine whether
cells labeled 6 d postinjury had commenced regeneration of mye-
lin. mG+ cells showed evidence of differentiation: they exhibited
complex multiprocess morphologies and APC+ cell bodies char-
acteristic of premyelinating OLs (Fig. 1D). However, no mG+
myelin was visible at 14DPV. Taken together, these results conﬁrm
that the virus infected dividing NG2-expressing glial progenitors,
and not postmitotic, myelinating OLs. Furthermore, we conﬁrm
that regenerated myelin membranes take at least 2 wk to initially
form (18).
Regenerating Myelin Sheaths Are Evident 1 mo After Virus Injection.
To determine whether the reporter system targeted regenerating
myelin membranes, we examined longitudinally sectioned spinal
cords of injured mice killed at 1 mo post virus (MPV) injection,
when remyelination was predicted to be well under way (18).
Sections contained OL-associated mG+ sheaths (Fig. 2), which
were hollow as expected (Fig. 2D) and ﬁlled with neuroﬁlament
(NF)+ axons (Fig. 2F). Sheaths exhibited contactin-associated
protein 1 (CASPR1)+ paranodes at each end, indicating
a reconstituted nodal structure (Fig. 2F). GFP signal within OL-
regenerated sheaths colocalized with the marker of compact
myelin, myelin basic protein (MBP; Fig. 2E). OL somata were
remotely connected to multiple myelin sheaths by ﬁne processes.
The myelin reporter allowed us to map many of the mG+ myelin
sheaths to mG+ cell bodies immunopositive for the OL marker
APC (Fig. 2C). Physical parameters (length and thickness) of
mG+ regenerated myelin were quantiﬁed by confocal microscopy
(Figs. 3 and 4). Other mG+ internodes exhibited an mG+ soma
with DAPI+ nucleus juxtaposed to the exterior of each sheath
(Fig. 5 A and B) and immunopositivity for P0 and periaxin (Fig. 5
D and E), characteristic of peripheral myelin produced by SCs.
By using confocal microscopy, we observed coincident but also
nonoverlapping regions of mG and MBP indicating reporter la-
beling of noncompact and compact myelin. To determine whether
reporter-labeled regenerated myelin was multilamellar and com-
pact, we performed immuno-EMon tissue sections stained with an
anti-GFP primary, followed by a secondary antibody conjugate
made with quantum dot nanocrystals (Qdots; ∼4 × 10 nm in
length) that ﬂuoresce under UV light and are also visible by EM.
We conﬁrmed GFP/Qdot colocalization by confocal microscopy
(Fig. 2G) and visualized Qdots of the appropriate size (4 × 10 nm)
labeling compact, multilamellar myelin in injured mice at 3 MPV
(Fig. 2 H–L).
Quantitative Characterization of Myelin Sheaths in Uninjured Controls.
To establish a baseline for our experiments in the injury model, we
quantiﬁed the structural characteristics of normal myelin in un-
injured reporter mice. Animals received a single thoracic microin-
jection of virus at postnatal day (P) 4 or P5, when many NG2+
progenitor cells undergo proliferation before differentiating into
myelinating cells. Animals were killed as age-matched, uninjured
adult controls. They exhibited mG+ myelin sheaths bounded by
CASPR1+ paranodes throughout the thoracic white matter (Fig.
3A). We quantiﬁed myelin dimensions by using confocal micros-
copy. The mean internode length of developmentally generated
myelin in thoracic segments 8 to 11 was 214± 97 μm, with a range of
28 to 495 μm (Fig. 3B). Consistent with previous EM studies (20,
37), sheath length and width were positively correlated (Fig. 3E).
We also determined g-ratio, the relationship of axonal diameter to
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Fig. 1. Cre-mediated recombination is evident in
glial progenitors, but not in myelin early after injury,
demonstrating targeted labeling of remyelinating
cells, and not preexisting myelin. (A) A low-power,
merged confocal z-series depicts perilesional mG+
cells 5 DPV, but, as expected, no mG+myelin sheaths
are yet evident. (B) Some mG+ cells are highly NG2+
with classic glial progenitor morphology (arrow-
heads). (C) mG+ cells exhibited BrdU+ nuclei 5 DPV
(arrowheads). More than 80%were BrdU+, although
some stained weakly, indicating likely BrdU dilution
with multiple cell divisions. Cells in C resemble im-
mature SCs. (D) At 14 DPV, still no mG+ sheaths were
evident, but many cells exhibited complex elongated
morphology and APC+ somata characteristic of pre-
myelinating OLs.
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total ﬁber diameter (including myelin), which is commonly used as
a measure of myelin thickness. The g-ratios we obtained (mean,
0.77 ± 0.11) were consistent with previous EM studies in adult
mouse spinal cord (38, 39).
Reporter-Labeled SCs Selectively Ensheathe Large Axons, Accounting
for One Third of Regenerated Sheaths at 1 MPV. We used confocal
microscopy to quantify mG+ myelin and ensheathed axonal
parameters at 1 MPV (Fig. 3 B–E). Regenerated sheaths were
signiﬁcantly shorter than average control sheaths by one-way
ANOVA: average OL-regenerated sheath length was 38 ± 21 μm,
only 18% of average uninjured length (range, 10–127 μm; P <
0.001), whereas mean SC sheath length was 92 ± 42 μm, 43% of
normal (range, 36–220 μm; P < 0.001; Fig. 3B). OL-regenerated
sheaths were also signiﬁcantly shorter than those of SCs (P <
0.001; Fig. 3B).
Surprisingly, mean g-ratio was not signiﬁcantly different be-
tween OL-regenerated sheaths (0.78 ± 0.10) and controls (0.77 ±
0.11; P > 0.05; Fig. 3C). Previous reports have relied upon thin
sheaths as a hallmark of regenerated myelin (14, 20, 22, 40), but
our data indicate that it can be surprisingly similar in thickness to
normal myelin. In contrast, mean mG+ SC g-ratio was signiﬁ-
cantly lower (0.70 ± 0.12; P < 0.05; Fig. 3C) compared with
uninjured central control sheaths, demonstrating that SCs retain
their capacity to produce thicker myelin than OLs (41) even
within the setting of postinjury central remyelination.
Strikingly, we found that SCs and OLs myelinated separate
axonal populations at 1 MPV (Fig. 3D). Regenerated OLs
ensheathed predominantly small axons (97% were 0.5–2 μm in
diameter), whereas SCs selectively ensheathed larger caliber
axons (50% were >2 μm in diameter; only 5% were <1 μm thick,
with a range of 0.90–0.96 μm). SCs are known to target axons
with diameters of 1 μm or greater in the periphery and in central
remyelination (19, 42). However, our data further indicate that
regenerated OLs predominantly avoid or are outcompeted for
ensheathment of large axons early after injury, providing a ﬁrst
look at how remyelinating OLs also initially target axons based
on caliber. Further, our data conﬁrm a known positive correla-
tion between sheath length and total ﬁber diameter in normal
myelin (37) and demonstrate that it occurs in regenerated my-
elin, even within the population of extremely short mG+ seg-
ments regenerated by OLs (Fig. 3E). Last, 36% of mG+ myelin
was SC-generated, indicating substantial contribution of pe-
ripheral-like sheaths to central remyelination.
SC-Regenerated Myelin Thickens Substantially Over Time. To exam-
ine the maturation of regenerating SC myelin, we used confocal
microscopy to quantify sheath and axonal dimensions at 1, 3, and
6 MPV. Mean length of SC remyelination did not change sig-
niﬁcantly between 1 and 6 MPV by one-way ANOVA (1 MPV,
92 ± 42 μm; 3 MPV, 100 ± 27 μm; 6 MPV, 89 ± 23 μm; P > 0.05).
However, mean g-ratio decreased signiﬁcantly at 3 and 6 MPV
(0.55 ± 0.09 and 0.54 ± 0.07, respectively) compared with 1 MPV
(0.70 ± 0.12; P < 0.001), indicating a substantial thickening of SC
myelin over time (Fig. 5), to a degree that is normal for pe-
ripheral but abnormally thick for central myelin (42). SC sheaths
also attained a complex morphology by 6 MPV, complete with
the Schmidt–Lanterman incisures typical of peripheral myelin
(Fig. 5C). This morphological identiﬁer reﬂects the signiﬁcant
advantage of using a membrane reporter for the purpose of
studying myelin regeneration.
OL-Regenerated Myelin Ensheaths Larger-Caliber Axons over Time
and Elongates Independently of Axonal Growth. To track the evo-
lution of OL-regenerated myelin, we examined mG+ sheath
dimensions and axonal parameters from 1 to 6 MPV. In contrast
to 1 MPV, OL-regenerated myelin ensheathed small- and large-
caliber axons at 3 and 6 MPV (Fig. 4 A and B). The percentage
of axons >2 μm in diameter ensheathed by regenerated OLs
increased from 4% at 1 MPV to 22% and 20% at 3 and 6 MPV,
respectively (Fig. 4B).
Strikingly, the mean length of OL-regenerated myelin in-
creased progressively between 1 and 6 MPV (1 MPV, 38 ± 21
μm; 3 MPV, 51 ± 29 μm; 6 MVP, 62 ± 24 μm; Fig. 4C). The
effect was particularly apparent on small-caliber axons (0.5–1 μm
in diameter), where there was considerable overlap of control
values with regenerated sheath lengths at 3 and 6 MPV (control,
mean, 96 ± 54 μm; range, 28–204 μm; 1 MPV, mean, 32 ± 19 μm;
range, 10–111 μm; 3 MPV, mean, 56 ± 30 μm; range, 13–194 μm;
6 MPV, mean, 72 ± 30 μm; range, 37–166 μm). Signiﬁcant mG+
sheath elongation was also apparent on medium caliber axons
(1–2 μm diameter), but not on large (>2 μm) axons. Interest-
ingly, the positive correlation between sheath length and axon
diameter evident at 1 MPV was reversed by 6 MPV (1 MPV,
Pearson r = 0.12; 6 MPV, Pearson r = −0.31). Our data indicate
that, whereas OL remyelination on small- and medium-caliber
axons elongates progressively, remyelination of the largest axons
is initiated later and does not appear to lengthen signiﬁcantly.
Perhaps myelin sheath reﬁnement on axons with a large surface
area takes longer than 6 mo or there could be a functional reason
for them to remain short.
We also examined the thickness of regenerated OLmyelin over
time (Fig. 4D). As we expected, mean g-ratio was signiﬁcantly
higher at 3 MVPI (0.82 ± 0.09), indicating thinner myelin
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Fig. 2. Regenerated myelin sheaths are evident by 1 MPV. (A) A low-power,
merged confocal z-series depicts regenerated myelin near the lesion, labeled
with the mG reporter (arrowheads) at 1 MPV. (B) Higher magniﬁcations
demonstrate that regenerated myelin (mG+) is abnormally short (∼50 μm;
merged z-series image). (C) Single z-plane from B reveals APC+/mG+ somata
(arrowheads) adjacent to mG+ myelin sheaths, typical of OL morphology. (D
and F) Each sheath is hollow when imaged in cross section (D, single z-plane,
arrowheads), and ﬁlled with an NF+ axon (F, arrowheads). (E and F) mG+
sheaths are MBP+ (E, arrowheads) and exhibit CASPR+ paranodes at both
ends (F, carets). (G) Speciﬁc Qdot localization is shown at the cut ends of
mG+ sheaths at the surface of this transverse spinal cord section, which was
imaged on a confocal microscope before processing for EM. (H–L) EM images
demonstrate unlabeled myelin (I) and Qdot labeling (yellow arrowheads;
∼4 × 10 nm in length) of compact, multilamellar regenerated myelin at various
magniﬁcations (H and J–L) in mice killed at 3 MPV.
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compared with controls (0.75 ± 0.10; P < 0.001). It is important to
note that confocal analysis of myelin thickness may not give exact
myelin measurements as seen by high-contrast EM of myelin
membranes. Nevertheless, despite the reliance on a correlative
distribution of mGFP along compact myelin, we ﬁnd remarkable
consistencies with g-ratios we have reported with EM (28). We
conﬁrm our previous EM studies and ﬁnd that the mean g-ratio
(and therefore myelin thickness) was not signiﬁcantly different
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myelin. (D) Regenerated OLs myelinate a high pro-
portion of small-caliber axons and few large axons;
the reverse is true of regenerated SCs. (E) Sheath
length and total ﬁber diameter are positively cor-
related in all groups (control, P < 0.0001; OL, P <
0.01; SC, P < 0.05; *P < 0.05 and ***P < 0.001).
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ship between axon diameter and internodal length.
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seen in A. (D) G-ratios of regenerated and uninjured
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points following injury (**P < 0.01, ***P < 0.001).
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between control and regenerated myelin at 1 MPV (0.78 ± 0.10;
P> 0.05) or at 6MPV (0.79± 0.09; P> 0.05). These g-ratio values
may reﬂect a developmental-like evolution of remyelination: initial
loose ensheathment by a few myelin lamina at 1 MPV, followed by
compaction of the lamina by 3 MPV, and then gradual thickening
of myelin (addition of membrane wraps) to reach average control
levels by 6 MPV. Perhaps most striking is that, when g-ratios are
binned by axonal size (<1 μm, 1–2 μm, <2 μm), there are no sig-
niﬁcant differences by one-way ANOVA between experimental
groups and controls at any time point interrogated (Fig. 4D).
Discussion
This study prospectively distinguishes between regenerating and
preexisting myelin sheaths to quantify the time course and phys-
ical development of spontaneously regenerated myelin. Contrary
to dogma, we ﬁnd that remyelinated segments with abnormal
proportions are transient, except on the largest surviving axons.
Most eventually attain lengths and thicknesses within the normal
range, indicating that endogenous remyelination is not typically
anemic as was previously assumed. Furthermore, our data dem-
onstrate that remyelination can elongate independently of axonal
growth, in contrast to stretch-based mechanisms proposed in de-
velopment (43, 44). We conclude that the full extent of remyeli-
nation cannot be assessed bymorphological criteria alone. Further
mechanistic insights into the regenerative process will require
empirical categorization of remyelinating membranes with the use
of similar reporter strategies.
Our data also establish an association between the subspecies of
remyelinating cell and the caliber of axon it ensheathes. In parallel
with normal peripheral myelination (45), SCs only remyelinated
axons larger than 1 μm in diameter. OLs, however, speciﬁcally
selected against or were outcompeted for large axons at early time
points, in surprising contrast to normal development. OLs, which
myelinate many axons simultaneously, could initially be limited in
myelinating multiple large surface areas by membrane production
rates or inadequate access to necessary metabolites, whereas SCs
may be more suitable to the task because they generate only
a single internode each (46). Alternatively, an SC/OL fate choice
could be induced in endogenous central progenitors by demyeli-
nated axons of a particular size (10). Recent studies demonstrate
that themyelinating potential of OLs is actively regulated by axons
(47) and that caliber-based selection of axons could be mediated
via axoglial integrin signaling (48). In either case, it is clear that
SCs are capable and perhaps even essential for quick restoration
of saltatory conduction and neuroprotection to large axons, at
least in the ﬁrst stages of recovery from trauma. Conversely, the
inability of SCs to myelinate small axons makes OLs indispensable
in central remyelination.
Conﬁrming earlier reports (18, 20), OL-regenerated myelin
was initially very short compared with normal myelin. SC-
regenerated sheaths were longer and thicker than their OL
counterparts, but still only approximately half as long as control
sheaths. Whereas SC sheath length was static over time, OL-
regenerated sheaths elongated on small and medium-sized
axons, remarkably reaching the normal range of intact, de-
velopmental controls. Furthermore, after 6 mo, we did not ﬁnd
extremely short myelin internodes of 20 μm or less, which were
initially common. The temporal loss of short internodes indicates
that some myelin was likely pruned over time, to make room for
elongation of neighboring sheaths. Although we do not have
direct evidence of this phenomenon, myelin plasticity must be
occurring and warrants future exploration. Last, our data suggest
a previously underappreciated level of plasticity not only in
myelin membranes, but also in reconstituted nodal structures.
The most striking ﬁnding of this study is the low abundance of
abnormally thin regenerated myelin, challenging a key assump-
tion in the ﬁeld. Previously, regenerated sheaths have been clas-
siﬁed in pathological conditions as falling into a very high g-ratio
range of 0.9 to 1.0 with thicknesses less than ∼20% of develop-
mental myelin (14, 19, 22). Many studies have reported a high
prevalence of very thin myelin surrounding lesion zones even
years after spinal cord injury (14, 22). Given our observations, it
is unlikely that a majority of long-standing, abnormally thin
myelin in zones of pathologic conditions such as trauma, stroke,
or disease is the result of incomplete myelin regeneration. It may
instead be derived from preexisting myelin that is undergoing
degeneration or reﬁnement (23–25). Our EM analysis indicates
the myelin reporter labels compact myelin and could be used at
this level to look at more accurate and detailed analysis of the
myelin wrapping and g-ratios of small-caliber axons. In addition,
a potential limitation of the reporter is the eventual exclusion of
membrane label from compact structures as has been previously
reported for myelin protein fusion reporters (49). Nevertheless,
the ﬁdelity to examine regenerated myelin indices at light and
EM levels makes this model system a potent new tool for ob-
serving many of the unanswered questions of the dynamic changes
injured myelin may undergo over time.
In conclusion, these studies reveal that remyelination following
central insult is a profoundly prolonged process of sheath re-
ﬁnement, leading us to reevaluate our conception of how myelin
is regenerated. We demonstrate that, even in the setting of
trauma, most regenerated myelin eventually attains remarkably
similar physical characteristics to myelin formed during de-
velopment. Now that we have a clearer understanding of the
robust nature of remyelination and the capacity for sheath plas-
ticity, we may also begin to design new studies to evaluate remye-
lination-directed therapies for spinal cord injury, stroke, and other
demyelinating disorders.
Methods
SI Methods provides additional information on surgical procedures
and methods.
Animals. A total of 24 Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/J mice (Jackson
Labs) were used in this study. All procedures were in accordance with a
protocol approved by the Animal Care and Use Committee of the University
of Washington.
Virus Production. A Phoenix–Moloney murine leukemia virus expression vector,
pLNpCRESN, with Cre recombinase under the control of the NG2 promoter has
previously been described and characterized (31). To generate retrovirus,
pLNpCRESNwas cotransfected with the VSV-G envelope vector into Phoenix-GP
mG DAPI
B   1 MPV
50 µmmG
A     1 MPV
C    6 MPV
25 µm
D    3 MPV
mG DAPI
mG DAPI mT
P0
E    6 MPV
25 µm mG DAPI PeriaxinCASPR1
Fig. 5. mG+ SC-regenerated sheaths are evident 1, 3, and 6 MPV. (A)
Merged confocal z-series depicts mG+ SC sheaths at 1 MPV. Arrowheads
indicate somata hugging each sheath, typical of SC morphology, which are
DAPI+ as seen in B (arrowheads in single z-plane). (C and D) By 3 and 6 MPV,
SC myelin gains complexity. (C) Arrowheads indicate a double-layered ap-
pearance in mG+ sheaths in a single z-plane. Carets indicate Schmidt–Lan-
terman incisures, characteristic of mature SC myelin. mT+ SC-regenerated
myelin is also evident. SC-regenerated sheaths are (D) P0+ and (E) periaxin+.
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packaging cells (American Type Culture Collection). Infectious virus particles
were harvested 48, 72, and 96 h posttransfection and concentrated via ultra-
centrifugation to 1 × 1010 infectious particles per microliter.
Confocal Microscopy and Quantitative Analysis.Multichannel confocal z-series
images were generated using a Nikon A1 Confocal System attached to a Ti-E
inverted microscope platform. To quantify myelin and axonal dimensions, all
mG+ sheaths within six longitudinal sections containing the lesion from each
animal were imaged (n = 2 each from ventral, central, and dorsal spinal cord).
Quantiﬁcation was performed by using NIS Elements software (Nikon).
Sheath length was measured along NF+ axons from one CASPR+ paranode
to the other. Sheath widths were measured in at least four locations in
ﬂattened z-stacks and averaged. Basal lamina, but not cell body, was in-
cluded in SC sheath width measurements. SC sheaths were identiﬁed by the
presence of an mG+ soma with DAPI+ nucleus hugging the exterior of the
sheath. OL sheaths were identiﬁed by the presence of attached thin pro-
jections from a satellite mG+/DAPI+ cell body. NF+ axonal diameter was
measured in at least two locations and averaged. Where NF antibody
penetration was weak (typical within the internode in heavily myelinated
regions), average width of both CASPR-labeled paranodes was taken as
a measure of axonal diameter.
Immunoelectron Microscopy. Tissues were prepared as described previously
(28). Brieﬂy, three injured mice were killed and perfused at 3 MPV with
ice-cold 3% (wt/vol) paraformaldehyde/0.5% glutaraldehyde. All steps were
performed on ice. Coronal sections of spinal cord 80 μm thick were made
on a Vibratome. Sections were rinsed in PBS solution, blocked in 2% BSA in
PBS solution, and incubated with rabbit anti-GFP (1:500; Millipore) in block
for 2 h followed by goat anti-rabbit Qdot 605 (1:100; Invitrogen) for 1 h in
block, and rinsed in PBS solution. Some sections were imaged immediately
on a confocal microscope to conﬁrm colocalization of GFP with Qdots. Sections
were then dehydrated and processed for EM as previously. Ultrathin sections
were imaged by using an JEM-1400 transmission electron microscope (JEOL)
with a Gatan Ultrascan 1000XP camera.
Statistical Analysis. Statistical signiﬁcance among groups was determined
by one-way ANOVA with Bonferroni multiple comparison posttest for three
or more groups or two-tailed, unpaired t test for two groups. Pearson cor-
relations were used to determine the relationship between sheath length
and axon or total ﬁber diameter. A CI of 95% and Prism software was used
for all comparisons (GraphPad). Results in the text are reported ±SD.
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SI Methods
Contusion Spinal Cord Injury. Female mice aged 3 mo were anes-
thetized via i.p. injection of ketamine (100 mg/kg; Fort Dodge
Animal Health) and xylazine (20mg/kg; Lloyd Laboratories). The
skin of the back was shaved and scrubbed with Betadine and
ethanol. s.c. local anesthetic agent (lidocaine and bupivacaine
1 mg/kg each; Hospira) was injected, the skin was opened, and a
dorsal laminectomy was performed at thoracic segment (T) 9 or
T10. An impact probe was lowered onto the dural surface and
displaced by 0.43 mm (i.e., moderate injury) by using The Ohio
State University contusion device. Gelfoam was placed on the
dural surface, and muscle and skin were closed in layers. Animals
were kept on a heating pad (38 °C) until fully awake. s.c. warm
Ringer solution was given for hydration, and gentamicin (4.8 mg/
kg; APP) and twice-daily buprenorphine (0.05 mg/kg; Reckitt
Benckiser) were administered for 7 and 2 d, respectively. Manual
bladder expression was performed twice daily until voluntary
control returned.
Virus Microinjection. Six days postcontusion, animals were anes-
thetized as described earlier, and the laminectomy site was reex-
posed. Two 2-μL injections of virus were made into the dorsal
columns 0.5 mm rostral and 0.5 mm caudal to the lesion epicenter
at a rate of 0.5 μL/min. Themicropipette was slowly extracted after
2 min. Wound closure and postoperative care were as described
earlier. Animals received s.c. warm Ringer solution and bupre-
norphine and i.p. BrdU (10 mg/mL).
Uninjured control animals (n = 3) received a 1-μL spinal
microinjection of virus to label developmentally generated my-
elin. Postnatal day 4 to 5 pups were anesthetized on ice for 5 min
and maintained on an ice pack during injection. Skin of the back
was sterilized as described earlier, and a hemilaminectomy was
performed at T9 or T10. Virus was injected just lateral of the
dorsal spinal artery at a rate of 0.5 μL/min at 0.1 to 0.2 mm below
the dural surface, and the micropipette was extracted after
a 2-min wait. Gelfoam was placed on the dural surface, and the
skin was closed with Vetbond. Pups were kept on a heating pad
(38 °C) until fully awake. Pups received s.c. buprenorphine (0.03
mg/kg) and were returned to the nest. They were allowed to
mature until euthanasia at age 3 to 4 mo.
Tissue Preparation.Mice were given an overdose of Beuthanasia-D
(Schering-Plough) and intracardiac perfusion with Ringer solu-
tion to exsanguinate, then with 4% paraformaldehyde. Injured
mice were killed at 5 d post virus injection (DPV; n = 4), 14 DPV
(n = 4), 1 MPV (n = 5), 3 MPV (n = 5), or 6 MPV (n = 5). Spinal
cords were postﬁxed in 4% paraformaldehyde overnight, equil-
ibrated in 30% sucrose for cryoprotection, frozen in Optimum
Cutting Temperature medium (Ted Pella), and sectioned lon-
gitudinally onto slides at 20 to 40 μm.
Immunohistochemistry. Slides were rinsed with PBS solution for
10 min and blocked for 60 min in PBS solution with 5% donkey
serum (Jackson ImmunoResearch) and 0.5% Triton X-100
(Amresco). Sections were incubated for 24 to 48 h at 4 °C in block
with primary antibodies (as detailed later), then at 4 °C overnight
in block with appropriate secondary antibodies: anti-mouse, anti-
chicken, anti-rat, or anti-rabbit 647 or 594 (1:300; Invitrogen).
Tissue was rinsed ﬁve times for 10 min each in PBS solution. The
last rinse included the nuclear marker DAPI (1:1,000). Slides
were coverslipped with Gelvatol. Primary antibodies included
rabbit anti-neural/glial antigen 2 (1:500; gift of W. Stallcup,
Sanford–Burnham Medical Research Institute, La Jolla, CA), rat
anti-BrdU (1:500; Novus Biologicals), pan-axonal neuroﬁlament
mouse anti–SMI-312R and -311R (1:500; Covance), rabbit anti–
contactin-associated protein (1:100; gift of S. Trimmer, Univer-
sity of California, Davis, CA), mouse anti–APC-CC1 (1:200;
Calbiochem/EMD Biosciences), rabbit anti-myelin basic protein
(Millipore), and chicken anti-P0 (1:100; AvesLabs) or rabbit
anti-periaxin (1:2,000; gift of P. Brophy, University of Edinburgh,
Edinburgh, United Kingdom).
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Fig. S1. Experimental design. (Upper) Double-ﬂuorescent Cre-reporter mice ubiquitously express membrane-targeted tandem dimer Tomato (mT) before Cre-
mediated excision, after which cells express membrane-targeted GFP (mG). CMV enhancer/chicken β-actin core promoter (pCA) drives expression of the loxP-
ﬂanked mT sequence followed by a polyadenylation signal (pA). An mG sequence is distal to the second loxP, followed by pA. Cre excision removes the mT
cassette and permits expression of mG [schematic adapted from Muzumdar et al. (1)]. (Lower) Mice received thoracic contusion followed 6 d later by per-
ilesional injection of high-titer retrovirus to deliver a neural/glial antigen 2 (NG2) promoter-driven Cre sequence to dividing cells. Mice were killed at ﬁve time
points after injury and cords examined for mG+ myelin sheaths.
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